US 12,453,826 B2
Inhaler device
David Gregory Ahern, Cambridge (GB); Robin Craig Cocker, Cambridge (GB); Ewen Humphrey Christie, Cambridge (GB); Christopher Iain Davidson, Cambridge (GB); James Anthony Tibbatts, Cambridge (GB); Paul Christopher Edward Mutti, Cambridge (GB); and James Terence Collins, Cambridge (GB)
Assigned to Sandoz AG, Basel (CH)
Appl. No. 17/264,404
Filed by SANDOZ AG, Basel (CH)
PCT Filed Aug. 2, 2019, PCT No. PCT/GB2019/052184
§ 371(c)(1), (2) Date Jan. 29, 2021,
PCT Pub. No. WO2020/025977, PCT Pub. Date Feb. 6, 2020.
Claims priority of application No. 1812671 (GB), filed on Aug. 3, 2018.
Prior Publication US 2021/0386945 A1, Dec. 16, 2021
Int. Cl. A61M 15/00 (2006.01)
CPC A61M 15/0045 (2013.01) [A61M 15/0025 (2014.02)] 22 Claims
OG exemplary drawing
 
1. An inhaler device comprising;
a chassis defining an interior chamber and an actuation mechanism within the interior chamber, the actuation mechanism comprising:
an indexing system comprising a first indexer for advancing a first medicament carrier and a second indexer for advancing a second medicament carrier; and
a common actuator for controlling movement of the first and second indexers;
wherein the common actuator is movable between a first position, a second position, and an intermediate position between the first and second positions;
wherein the first medicament carrier and the second medicament carrier each separately comprises an elongate blister strip of medicament,
and wherein progression of the first indexer is disproportional to progression of the second indexer.